Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
ACS Medicinal Chemistry Letters|April 21, 2015
Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related PainMark D Andrews, Kerry Af Forselles, Kevin Beaumont, et al.Journal of Medicinal Chemistry|March 5, 2021
Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and OptimizationJean-Olivier Zirimwabagabo, Ameera B A Jailani, Paris Avgoustou, et al.Journal of Medicinal Chemistry|November 17, 2015
Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial ActivityCharles E Mowbray, Stéphanie Braillard, William Speed, et al.The Journal of Pharmacology and Experimental Therapeutics|August 16, 2014
Inhibition of TRPM8 channels reduces pain in the cold pressor test in humansWendy J Winchester, Katrina Gore, Sophie Glatt, et al.Bioorganic & Medicinal Chemistry Letters|September 2, 2011
Design and synthesis of long acting inhaled corticosteroids for the treatment of asthmaDavid S Millan, Stephen A Ballard, Sara Chunn, et al.Journal of Medicinal Chemistry|September 1, 2010
Inhalation by design: novel ultra-long-acting β(2)-adrenoreceptor agonists for inhaled once-daily treatment of asthma and chronic obstructive pulmonary disease that utilize a sulfonamide agonist headgroupPaul A Glossop, Charlotte A L Lane, David A Price, et al.Journal of Medicinal Chemistry|October 29, 2021
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral LeishmaniasisCharles E Mowbray, Stéphanie Braillard, Paul A Glossop, et al.ACS Pharmacology & Translational Science|August 25, 2020
Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 ReceptorParis Avgoustou, Ameera B A Jailani, Jean-Olivier Zirimwabagabo, et al.Journal of Medicinal Chemistry|August 30, 2011
Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary diseasePaul A Glossop, Christine A L Watson, David A Price, et al.Pageof 2